Indoor Air Pollution

Slide 1 · Indoor Air Pollution

Exposure, mechanisms, and clinicopathologic consequences

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Classify major indoor airborne pollutants by source and biologic action.

Explain combustion-related inflammation, hypoxic injury, and carcinogenesis.

Distinguish infectious, allergic, and toxic indoor-air presentations.

Apply exposure-oriented reasoning to representative clinical scenarios.

Slide 3 · Indoor air is an exposure compartment

Indoor emission

Limited air exchange

Pollutant accumulation

Inhalational exposure

The indoor environment can intensify exposure when emissions persist and ventilation is inadequate.

Slide 4 · Four principal indoor hazard families

Combustion

Smoke, particles, CO, nitrogen oxides

Biologic

Microbes and allergens

Geologic

Radon and its decay products

Materials

Formaldehyde and asbestos

Category describes source; Clinical consequences depend on the agent and dose.

Slide 5 · Ventilation changes the exposure context

Increasingly sealed buildings may retain internally generated pollutants.

The same indoor space can contain gaseous, particulate, and biologic hazards.

Poor air exchange is a potential contributor—not a universal explanation—for symptoms.

Risk assessment must link a source, a plausible route, and an outcome.

Slide 6 · From pollutant source to clinical effect

Source

Airborne agent

Inhalation

Tissue response

Clinical disease

Different agents may produce irritation, hypoxia, allergy, infection, or malignancy.

Slide 7 · Why individuals respond differently

Host susceptibility varies with age, genetic predisposition, and tissue sensitivity.

Asthma and chronic pulmonary disease can increase the impact of irritant exposure.

Exposure intensity, duration, and mixed pollutants complicate simple risk thresholds.

A safe level inferred for a population need not predict every individual response.

Slide 8 · Indoor versus outdoor air: Overlapping hazards

Shared hazards

Carbon monoxide and nitrogen dioxide occur in both settings.

Particulate exposure may arise from combustion sources.

The respiratory system is a principal entry site.

Indoor-specific emphasis

Confinement can concentrate locally emitted pollutants.

Building materials introduce additional volatile compounds.

Indoor animals, dust and moisture influence bioaerosols.

Slide 9 · Organ responses depend on pollutant class

Agent class

Principal pathway

Representative effect

Combustion gases

Irritation or oxygen transport

Asthma symptoms; systemic hypoxia

Particles

Airway/alveolar inflammation

Respiratory infection susceptibility

Bioaerosols

Infection or sensitization

Pneumonia; rhinitis/asthma

Radon

Ionizing radiation

Lung carcinoma

Slide 10 · Domestic combustion: Source diversity

Solid biomass

Wood, dung, charcoal

Other fuels

Kerosene, lignite, peat

Coal combustion

Smoke and aromatic compounds

Cooking oil

Volatile aromatic compounds

Fuel and cooking practices influence the mixture encountered indoors.

Slide 11 · Household fuel burning is a global exposure

Approximately one-third of the world’s people were estimated to burn carbon-containing fuel in their homes.

Cooking, heating, and lighting are relevant activities.

The specified fuels include wood, dung, charcoal, kerosene, lignite, and peat.

Household burning represents everyday domestic exposure, not only an industrial hazard.

Slide 12 · Combustion creates mixed airborne hazards

Burning organic material

Nitrogen oxides + carbon species

Particles and irritants

Respiratory exposure

Combustion is not a single-pollutant phenomenon.

Slide 13 · Smoke acts first as a respiratory irritant

Organic combustion smoke contains various oxides of nitrogen and carbon particulates.

Inhaled irritants contact respiratory mucosa and can provoke local injury.

Combustion smoke exposure is associated with increased susceptibility to lung infections.

The exact disease depends on the mixture and the exposed host.

Slide 14 · Smoke and respiratory infection susceptibility

Inhaled smoke

Airway irritation

Impaired airway environment

Greater infection susceptibility

Smoke-related infection susceptibility does not establish which pathogen causes an illness.

Slide 15 · Particles can reach the distal lung

Fine particles are more likely than larger particles to reach the distal respiratory tract.

Particles reaching alveoli may be engulfed by macrophages and neutrophils.

Activated phagocytes release inflammatory mediators.

Particle deposition and innate immune activation explain a pulmonary inflammatory response.

Slide 16 · Alveolar particulate response

Inhaled fine particles

Alveolar deposition

Macrophage / neutrophil uptake

Inflammatory mediators

Schematic: Biologic response to respirable particles; No tissue photomicrograph.

Slide 17 · Local irritation versus systemic consequence

Airway-dominant injury

Smoke and nitrogen oxides irritate mucosal surfaces.

Inflammatory responses alter airway function.

Preexisting lung disease increases vulnerability.

Systemic hypoxic injury

CO does not need to irritate the airway.

CO binds hemoglobin and compromises oxygen carriage.

Neurologic injury may be prominent.

Slide 18 · Polycyclic aromatic hydrocarbons are a separate hazard

Volatile compounds containing PAHs may arise from cooking oils and coal burning.

These emissions are important indoor hazards in lower-resource settings, notably parts of Asia.

Some organic combustion smoke may contain carcinogenic PAHs.

PAH exposure links combustion environments to potential long-term cancer risk.

Slide 19 · A carcinogen can require metabolic activation

Inhaled PAH

Cytochrome P450 metabolism

Reactive metabolite

DNA adduct / mutation risk

The adjacent toxicology discussion uses benzo[a]pyrene as an example of activation.

Slide 20 · A crucial distinction: Presence versus cancer causation

Finding a potential carcinogen in smoke identifies a biologic hazard.

Dose, duration, absorption, and host factors modify eventual risk.

Cancer risk cannot be calculated from simple detection of PAHs in indoor air.

Mechanistic plausibility does not determine an individual’s probability of developing malignancy.

Slide 21 · Tobacco smoke is a major indoor pollutant

Tobacco smoke is a major and frequently encountered indoor pollutant.

Environmental or secondhand inhalation exposes people other than active smokers.

Passive tobacco exposure is associated with lung cancer in nonsmokers.

Indoor tobacco exposure should be separated from deliberate active smoking.

Slide 22 · Important constituents of tobacco smoke

Constituent

Principal biologic effect

Carbon monoxide

Impaired oxygen transport/utilization

Nitrogen oxides

Ciliary toxicity; mucosal irritation

Formaldehyde

Ciliary toxicity; mucosal irritation

Polycyclic aromatic hydrocarbons

Carcinogenesis

Benzo[a]pyrene

Carcinogenesis

Slide 23 · Secondhand tobacco smoke: Causal reasoning

Environmental smoke

Inhalation by nonsmoker

Exposure to carcinogens

Increased lung-cancer risk

Passive inhalation can increase lung-cancer risk in nonsmokers.

Slide 24 · Smoke constituents have different biologic actions

Carcinogens contribute to mutation-related risk.

Irritants affect mucosal and ciliary function.

Carbon monoxide reduces blood oxygen carriage.

A single indoor emission can therefore generate multiple pathologic outcomes.

Slide 25 · Carbon monoxide: An indoor combustion emergency

Incomplete oxidation of hydrocarbons generates carbon monoxide (CO).

Potential sources include furnaces, engines, cigarettes, and gasoline-powered generators.

Poorly ventilated or enclosed settings are especially concerning.

CO exposure produces systemic toxicity rather than a simple irritant syndrome.

Slide 26 · Common environments with CO generation

Heating

Faulty or poorly vented furnace

Power

Gasoline-powered generator

Transport

Running engine in an enclosure

Smoking

Cigarette combustion

All listed scenarios involve fuel combustion and potential enclosed-space exposure.

Slide 27 · Carbon monoxide cannot be detected by smell

CO is colorless, tasteless, odorless, and nonirritating.

Lack of obvious warning sensations makes exposure difficult to recognize.

CNS depression may evolve insidiously.

A plausible source and multiple affected occupants can be more informative than odor.

Slide 28 · CO causes functional anemia without loss of hemoglobin

Carbon monoxide inhalation

High-affinity hemoglobin binding

Carboxyhemoglobin

Reduced oxygen carriage

Hemoglobin binds carbon monoxide with approximately 200 times the affinity for oxygen.

Slide 29 · The carboxyhemoglobin mechanism

CO occupies oxygen-binding sites on hemoglobin.

The resulting carboxyhemoglobin cannot transport oxygen normally.

Systemic hypoxia follows as functional oxygen-carrying capacity declines.

Neurologic manifestations reflect tissue vulnerability to inadequate oxygen delivery.

Slide 30 · Why the brain is vulnerable in CO poisoning

Reduced blood oxygen delivery

Cerebral hypoxic injury

Basal ganglia involvement

Neurologic sequelae

Hypoxic injury is especially prominent in the basal ganglia and lenticular nuclei.

Slide 31 · Acute CO poisoning can be deceptive

Acute exposure may cause CNS depression, unconsciousness, or death.

Cherry-red skin or mucosal coloration can occur in some light-skinned individuals.

That coloration is not a reliable exclusion or screening feature.

Rapid deaths may occur before visible morphologic changes develop.

Slide 32 · CO poisoning has nonspecific tissue morphology

With longer survival the brain may be mildly edematous.

Punctate hemorrhages and hypoxia-related neuronal changes may occur.

The changes reflect systemic hypoxia rather than a CO-specific histologic lesion.

Absence of characteristic morphology cannot exclude severe exposure.

Slide 33 · Persistent exposure creates cumulative neurologic risk

Stable carboxyhemoglobin can accumulate during prolonged exposure.

Slowly developing hypoxia may cause widespread CNS ischemic injury.

Persistent deficits may affect memory, vision, hearing, and speech.

Chronic toxicity may be less dramatic than acute collapse.

Slide 34 · CO exposure: Recognition pathway

Compatible source/history

Suspect CO toxicity

Measure blood COHb

Interpret with clinical context

Blood carboxyhemoglobin measurement directly supports assessment of CO exposure.

Slide 35 · CO toxicity versus airway irritancy

Feature

Carbon monoxide

Combustion smoke/NO₂

Sensory warning

Odorless; nonirritating

May irritate airways

Principal injury

Impaired oxygen carriage

Respiratory irritation/inflammation

Clinical emphasis

CNS hypoxia

Airway symptoms / asthma

Useful clue

Source + COHb testing

Exposure + respiratory response

Slide 36 · Clinical case: Sudden symptoms in a closed room

Hypothetical teaching vignette

An occupant is found confused after a gasoline generator has run in an enclosed space.

There is no unusual smell and little cough.

Question: Which indoor agent and pathogenic mechanism best explain the presentation?

Slide 37 · Case resolution: Generator-associated CO injury

Combustion in enclosure

Carbon monoxide accumulation

Carboxyhemoglobin

Systemic hypoxia / CNS effects

Test the exposure hypothesis using blood carboxyhemoglobin and the clinical context.

Slide 38 · Nitrogen dioxide is also an indoor pollutant

Nitrogen dioxide occurs in both indoor and outdoor polluted air.

Combustion can introduce nitrogen oxides into indoor air.

Nitrogen dioxide is associated with increased airway reactivity and reduced lung function.

Children and people with asthma are particularly relevant susceptible groups.

Slide 39 · Nitrogen dioxide: Respiratory susceptibility

Population

Associated effect

Healthy adults

Increased airway reactivity

People with asthma

Decreased lung function

Children

Increased respiratory infections

Slide 40 · Asbestos is an additional indoor-air concern

Asbestos is among the additional agents that can contaminate indoor air.

Inhaled mineral dusts are associated with pneumoconioses.

Asbestos-related fibrosis and cancers have a distinct mechanism from CO or radon.

Do not confuse radon, CO, and asbestos: Their mechanisms are distinct.

Slide 41 · Bioaerosols comprise two clinical groups

Infectious agents

Airborne microbes

Allergens

Pet dander, mites, fungi, molds

Aerosol exposure may cause disease through infection or through allergic responses.

Slide 42 · Infectious bioaerosols: Textbook examples

Legionnaires’ disease is a representative illness in the infectious bioaerosol group.

It also includes viral pneumonia and the common cold.

The presence of an airborne organism creates an infectious exposure pathway.

Agent-specific confirmation is not established by a generic indoor-exposure history.

Slide 43 · Infectious indoor aerosol pathway

Microbial aerosol

Respiratory inhalation

Infection

Disease manifestation

Pathway illustrates exposure; Actual acquisition depends on organism and circumstances.

Slide 44 · Indoor allergens are not synonymous with infection

Pet dander and dust mites represent allergenic exposures.

Fungi and molds also contribute allergens in indoor environments.

Allergic responses can be distressing without a microbial infection.

An allergen-associated illness should not automatically be treated as pneumonia.

Slide 45 · Allergen-associated respiratory illness

Indoor allergen

Susceptible host

Allergic response

Rhinitis / asthma

Eye irritation may accompany allergen-related indoor-air presentations.

Slide 46 · Distinguish microbial from allergenic aerosols

Comparison

Infectious bioaerosol

Allergenic bioaerosol

Representative source

Microorganisms

Dander, dust mites, molds

Primary process

Infection

Allergic response

Examples

Pneumonia; common cold

Rhinitis; asthma

Reasoning

Consider pathogen

Consider allergen exposure

Slide 47 · Clinical case: Symptoms in a damp indoor space

Hypothetical teaching vignette

An individual develops recurrent rhinitis and wheeze when spending time in a room with visible mold.

Question: Is the strongest hypothesis an infectious illness or allergen-associated disease?

What additional clinical history would help distinguish the two?

Slide 48 · Case interpretation: Exposure is not a diagnosis

The symptom pattern supports considering allergen-associated rhinitis or asthma.

Molds can be relevant allergens, but exposure alone does not prove etiology.

Infectious disease requires compatible clinical evidence and appropriate assessment.

Ask about symptom timing, other triggers, and response outside the building.

Slide 49 · Radon is a soil-derived radioactive gas

Radon arises naturally from uranium present in soil.

It can enter homes and contribute to indoor exposure.

The principal long-term pathologic concern is lung carcinoma.

Radon differs mechanistically from smoke irritation and CO poisoning.

Slide 50 · Radon hazard originates below the building

Uranium in soil

Radon gas

Indoor accumulation

Inhalation

Original conceptual environmental pathway, not a building measurement.

Slide 51 · Radon daughters deliver the damaging radiation

Polonium-214 and polonium-218 are alpha-emitting radon decay products.

These daughter products emit alpha particles.

Inhaled daughter products may deposit in the lung.

Chronic exposure is associated with pulmonary carcinoma in uranium miners.

Slide 52 · Radon carcinogenic mechanism

Radon inhalation

Polonium decay products

Alpha-particle exposure in lung

Cancer risk

The diagram depicts a carcinogenic pathway, not a quantified dose-response.

Slide 53 · Evidence is strongest for occupational radon exposure

Sustained radon exposure can cause lung carcinoma in uranium miners.

Household exposures are also considered a lung-cancer hazard.

Estimating risk from low-level domestic exposure is less straightforward.

Evidence for a hazard is not a case-specific diagnosis.

Slide 54 · Radon and tobacco have interacting risk contexts

Coexisting tobacco exposure is particularly concerning in radon-exposed people.

Tobacco smoke is independently carcinogenic in the respiratory tract.

Co-exposure is relevant when taking an environmental risk history.

An individual joint-risk estimate needs appropriate exposure and epidemiologic data.

Slide 55 · Textbook radon burden estimates need context

A textbook-cited US EPA estimate is roughly 21,000 radon-related lung-cancer deaths each year.

It reports roughly 2,900 among people who have never smoked.

These numbers are reproduced as textbook-attributed estimates, not current-year surveillance.

Radon is identified as a major lung-cancer cause in nonsmokers.

Slide 56 · Radon versus carbon monoxide: Incompatible mechanisms

Radon

Radioactive gas associated with uranium-bearing soil.

Alpha-emitting decay products affect the lung.

Primary described long-term endpoint: Lung carcinoma.

Carbon monoxide

Gas released by incomplete hydrocarbon combustion.

Binds hemoglobin and decreases oxygen delivery.

Acute or chronic hypoxic neurologic injury.

Slide 57 · Formaldehyde can originate in indoor materials

Manufactured building materials are a recognized formaldehyde source.

Cabinetry, furniture, and adhesives are potential emission sources.

Inadequately ventilated housing may permit airborne accumulation.

This is a source-to-exposure issue, not necessarily a visible material defect.

Slide 58 · Materials, ventilation, and mucosal exposure

Material source

Formaldehyde release

Poor ventilation

Inhalation and mucosal contact

Qualitative schematic: Pollutant concentrations cannot be inferred from this sequence.

Slide 59 · Formaldehyde causes mucosal irritation

Formaldehyde exposure can cause breathing difficulty and burning of the eyes and throat.

Irritant effects were described at concentrations of 0.1 ppm or higher.

It also identifies asthma attacks as a possible response.

This concentration should not be treated as a universal individual-response threshold.

Slide 60 · Formaldehyde has acute and chronic hazard dimensions

Immediate manifestations

Eye and throat burning.

Breathing difficulty.

Triggering of asthma attacks.

Long-term classification

Formaldehyde is classified as carcinogenic to humans and animals.

Carcinogenicity does not predict that every exposed person develops cancer.

Avoid inferring individual risk from a symptom alone.

Slide 61 · Comparison of indoor chemical hazards

Agent

Dominant acute issue

Long-term concern

Carbon monoxide

Systemic hypoxia

Neurologic sequelae

Formaldehyde

Mucosal irritation

Carcinogenic classification

Radon

Usually not an irritant syndrome

Lung cancer

Smoke/PAHs

Airway irritation

Carcinogen exposure

Slide 62 · Sick building syndrome is a symptom pattern

The syndrome has been described among office workers who spend long periods indoors.

Headache and respiratory complaints are characteristic.

It is a descriptive syndrome rather than proof of one causative chemical.

A careful exposure assessment must avoid premature causal attribution.

Slide 63 · Its underlying cause remains uncertain

No single underlying causal agent has been established.

One or more indoor pollutants may contribute.

Poor ventilation is proposed as a possible contributing condition.

Do not label all nonspecific building symptoms as a confirmed toxic exposure.

Slide 64 · Sick building syndrome: Hypothesis map

Prolonged building occupancy

Potential multiple indoor exposures

Headache / respiratory symptoms

Cause often unresolved

This is a hypothesis map only; The causal explanation remains unresolved.

Slide 65 · Symptom patterns orient indoor exposure assessment

Presentation

Candidate pathway

Discriminating clue

Confusion / collapse

CO-related hypoxia

Fuel-burning source

Wheeze / rhinitis

Allergenic aerosol

Exposure-linked symptoms

Burning eyes / throat

Irritant gas / formaldehyde

Material or combustion source

Long-latency cancer

Radon / smoke carcinogens

Chronic exposure history

Slide 66 · Exposure history should be source-specific

Ask which fuels, heating appliances, and generators operate indoors.

Review tobacco exposure and visible or documented building materials.

Consider dampness, pets, dust, ventilation, and occupancy patterns.

Separate agent-specific evidence from general symptom associations.

Slide 67 · Three levels of causal evidence

Exposure clue

Source plausibly present

Health pattern

Manifestations fit agent

Confirmation

Agent-specific tests when available

An exposure history alone is insufficient to establish an individual diagnosis.

Slide 68 · Prevention targets the exposure pathway

Identify emissions

Reduce or isolate source

Improve air exchange

Reassess exposure

Conceptual exposure control; Specific interventions require appropriate environmental and clinical advice.

Slide 69 · Integrated case: Unexplained office complaints

Hypothetical teaching vignette

Several office workers describe headache and respiratory symptoms during long indoor workdays.

The building has limited fresh-air exchange; No individual agent has been measured.

Question: What can be concluded, and what remains uncertain?

Slide 70 · Case resolution: Avoid overdiagnosis

The cluster is compatible with the symptom pattern called sick building syndrome.

Poor ventilation is a plausible factor, not a confirmed mechanism.

Evaluate occupancy-linked symptoms and possible pollutant sources.

Do not claim a specific toxin without supporting environmental or medical findings.

Slide 71 · Clinical synthesis: Four mechanisms, different endpoints

Irritants and particles predominantly affect airway and alveolar function.

Carbon monoxide impairs systemic oxygen transport.

Bioaerosols can cause infection or allergic manifestations.

Radon and certain organic chemical exposures raise carcinogenic concerns.

Slide 72 · High-yield mechanism comparison

Exposure

Mechanism

Selected clinicopathologic consequence

Smoke particles

Airway/alveolar inflammation

Infection susceptibility

CO

Carboxyhemoglobin formation

CNS hypoxia

Bioaerosols

Microbial infection / allergy

Pneumonia / rhinitis / asthma

Radon daughters

Alpha radiation

Lung carcinoma

Formaldehyde

Mucosal irritation

Burning eyes/throat, asthma attacks

Slide 73 · Key interpretive principles

Multiple pollutants can coexist in a home or workplace.

Different manifestations suggest different mechanisms; They are not interchangeable.

Established toxic effects must be distinguished from uncertain exposure associations.

Exposure assessment requires agent-specific evidence rather than symptom pattern alone.

Slide 74 · Primary reading

Robbins, Cotran & Kumar: Pathologic Basis of Disease, 11th edition.

Environmental Pollution: Indoor Air Pollution and related carbon monoxide discussion.

Effects of Tobacco; Cancer Risks From Exposures to Radiation.